drugset / Trial / NCT06792903

YM-101 Eye Drops in the Treatment of Dry Eye Syndrome

NCT06792903 ↗

Phase 0 Completed 30 enrolled Eye & ENT Hospital of Fudan University
RandomizedCrossoverQuadruple-blindTreatment

Summary

This study is a single-center, randomized, double-blind, placebo-controlled, cross-over clinical trial designed to evaluate the effectiveness and safety of YM-101 eye drops for the treatment of dry eye syndrome, using a placebo as a control.

Timeline

Start
2024-04-23
Primary completion
2025-05-15
Completion
2025-05-15

Drugs

EvaluationDrugModalityDoseRoute
Subject YM-101 Unknown — Topical

Indications